NOD2/CARD15 and the Paneth cell: Another piece in the genetic jigsaw of inflammatory bowel disease

Gut

Volumn 52, Issue 11, 2003, Pages 1533-1535

  Aldhous, M C ^a   Nimmo, E R ^a   Satsangi, J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ANGIOTENSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUCINE; LYSOZYME; PHOSPHOLIPASE A2; TRYPSIN;

APOPTOSIS; BACTERIAL FLORA; CARD15 GENE; CROHN DISEASE; GENE; GENE CONSTRUCT; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC ENGINEERING; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; MUTATIONAL ANALYSIS; NOD2 GENE; NOTE; PANETH CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; SEQUENCE HOMOLOGY; SMALL INTESTINE MUCOSA; ULCERATIVE COLITIS;

ANTI-INFECTIVE AGENTS; CARRIER PROTEINS; COLITIS, ULCERATIVE; CROHN DISEASE; DEFENSINS; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, NATURAL; INFLAMMATORY BOWEL DISEASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PANETH CELLS;

EID: 0242298205     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.11.1533     Document Type: Note

References (41)

1. Bhan AK, Mizoguchi E, Smith RN, et al. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev 1999;169:195-207.
2. Shanahan F. Therapeutic manipulation of gut flora. Science 2000;289:1311-12.
3. Arnott ID, McNeill G, Satsangi J. An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease. Aliment Pharmacol Ther 2003;17:1451-7.
4. Todd JA. Human genetics. Tackling common disease. Nature 2001;411:537-9.
5. Satsangi J, Morecroft J, Shah NB, et al. Genetics of inflammatory bowel disease: scientific and clinical implications. Best Pract Res Clin Gastroenterol 2003;17:3-18.
6. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
7. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
8. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations (erratum appears in Lancet 2002;360:806). Lancet 2001;357:1925-8.
9. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
10. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
11. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521-6.
12. Helio T, Halme L, Lappalainen M, et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003;52:558-62.
13. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002;359:1661-5.
14. Bairead E, Harmon DL, Curtis AM, et al. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet 2003;11:237-44.
15. Crichton DN, Arnott IDR, Watts D, et al. NOD2/CARD15 mutations in a Scottish Crohn's disease population. Gastroenterology 2002;122(suppl):M1420.
16. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-66.
17. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
18. Abreu MT, Taylor KD, Lin Y-C, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002;123:9-88.
19. Crohn BB, Ginzburg L, Oppenheimer GD. Landmark article Oct 15, 1932. Regional Ileitis. A pathological and clinical entity. By Burril B Crohn, Leon Ginzburg, and Gordon D Oppenheimer. J Am Med Assoc 1984;251:73-9.
20. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276:4812-18.
21. Inohara N, Ogura Y, Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol 2002;5:76-80.
22. Zouali H, Lesage S, Merlin F, et al. CARD4/NOD1 is not involved in inflammatory bowel disease. Gut 2003;52:71-4.
23. Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 2003;130:180-92.
24. Gutierrez O, Pipaon C, Inohara N, et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002;277:41701-5.
25. Rosenstiel P, Fantini M, Brautigam K, et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003;124:1001-9.
26. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003;278:8869-72.
27. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003;278:5509-12.
28. Chamaillard M, Philpott D, Girardin SE, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A 2003;100:3455-60.
29. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B in inflammatory bowel disease. Gut 1998;42:477-84.
30. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993-1000.
31. Oguro Y, Lala S, Xin W, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003;52:1591-7.
32. Lala S, Ogura Y, Osborne C, et al. Crohn's disease and the NOD2 gene: A role for Paneth cells. Gastroenterology 2003;125:47-57.
33. Ganz T. Paneth cells - guardians of the gut cell hatchery. Nat Immunol 2000;1:99-100.
34. Ayabe T, Satchell DP, Wilson CL, et al. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000;1:113-18.
35. Hooper LV, Stappenbeck TS, Hong CV, et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269-73.
36. Cunliffe RN, Rose FR, Keyte J, et al. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 2001;48:176-85.
37. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286:113-17.
38. Ghosh D, Porter E, Shen B, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002;3:583-90.
39. Wada A, Ogushi K, Kimuro T, et al. Helicobacter pylori-mediated transcriptional regulation of the human beta-defensin 2 gene requires NF-kappaB. Cell Microbiol 2001;3:115-23.
40. Wehkamp J, Fellermann K, Herrlinger KR, et al. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002;14:745-52.
41. Berrebi D, Maudinas R, Hugot JP, et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003;52:840-6.